Navigation Links
Studies Show Effect of BYDUREON™ on A1C and Weight for Up to Three Years
Date:6/24/2011

SAN DIEGO, June 24, 2011 /PRNewswire/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN), Eli Lilly and Company (NYSE: LLY) and Alkermes, Inc. (Nasdaq: ALKS) today announced results from long-term extensions of the DURATION-1 and 3 studies evaluating BYDUREON™ (exenatide extended-release for injectable suspension), an investigational medication for type 2 diabetes. The studies will be presented at the 71st Scientific Sessions of the American Diabetes Association.

Data from the DURATION-1 study showed that after three years, patients receiving BYDUREON experienced a significant reduction in A1C (1.6 percentage points), a measure of average blood sugar over three months, and weight (5.1 pounds) compared to baseline. (BYDUREON is not being studied as a weight-loss product.) BYDUREON-treated patients also experienced improvements from baseline in several cardiometabolic risk markers, including systolic blood pressure (-2.1 mmHg), total cholesterol (-9.9 mg/dL), LDL cholesterol (-7.0 mg/dL) and triglycerides (-12 percent).

Separately, results from the DURATION-3 study showed that at 84 weeks, patients treated with BYDUREON experienced significantly greater A1C reduction from baseline, sustained weight loss and a lower risk of hypoglycemia than patients treated with Lantus® (insulin glargine).  A1C reduction was 1.2 percentage points for BYDUREON compared with 1.0 percentage points for Lantus. Also, significantly more patients taking BYDUREON achieved an A1C of less than or equal to 6.5 percent. Patients on BYDUREON lost an average of 4.5 pounds while those on Lantus gained an average of 5.3 pounds, a difference of 9.8 pounds between the treatments.

"Faced with the progressive nature of type 2 d
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.; Eli Lilly and Company; Alkermes, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Pearl Therapeutics Advances Its Long-Acting Bronchodilator Combination Product Candidate into Four Additional Phase 2 Studies
2. Best of ASCO Features Two Studies Led by US Oncology Research Affiliated Physicians
3. Data from Clinical Studies of bioTheranostics CancerTYPE ID® and Breast Cancer Index(SM) Molecular Diagnostic Tests Presented at ASCO 2011 Annual Meeting
4. Pharmacyclics Reports Recent Developments From Clinical Studies of its Btk Inhibitor PCI-32765
5. Genomic Health Presents Ten New Studies in Breast, Colon and Prostate Cancers at the American Society of Clinical Oncology (ASCO) Annual Meeting
6. Additional Data From Multiple Phase 1 and 2 Studies of S*BIOs Novel JAK2 Inhibitor SB1518 Demonstrate Safety and Efficacy for Treatment of Symptomatic Myelofibrosis (MF)
7. Novartis highlights extensive data on numerous compounds at ASCO in multiple cancers, including Phase III studies in GIST and myelofibrosis
8. Genomic Health Announces Ten Studies Covering Breast, Colon and Prostate Cancers Accepted for Presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting
9. Lilly Oncology to Unveil Data From More Than 30 Studies at ASCO
10. New Studies Support CardioFocus HeartLight™ Endoscopic Ablation Systems Notable Treatment Results for Paroxysmal Atrial Fibrillation
11. Esperion Announces Results From Phase 1 Study and Four Preclinical Studies for ETC-1002
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... , July 28, 2014  VigeneTech, Inc, ... release of LEGENDplex™ Data Analysis Software, an OEM ... flow cytometers.  BioLegend develops and offers varieties of ... cytometers. With the support of VigeneTech,s data analysis ... accurately analyzed and easily reported ...
(Date:7/28/2014)... , July 28, 2014  UBM Medica US announces ... online community for medical imaging professionals, explored the complex ... payment models . The shift from fee-for-service ... how the radiologist,s reimbursement is determined in the new ... from leaders in the field, who recognized the complexity ...
(Date:7/28/2014)... BIRMINGHAM, Ala. , July 28, 2014 /PRNewswire-USNewswire/ ... Arthur J. Tipton , Ph.D., President and CEO ... of the Controlled Release Society (CRS) for the ... Society,s annual meeting on July 12 in ... than 40 countries.  The Controlled ...
Breaking Medicine Technology:VigeneTech Releases New Powerful Software for Flow Cytometry Data Analysis 2Diagnostic Imaging Delves into Measuring the Radiologist's Value 2Arthur J. Tipton, Ph.D., Named President of Controlled Release Society 2Arthur J. Tipton, Ph.D., Named President of Controlled Release Society 3
... Incorporated (NYSE: DGX ), the world,s leading ... it is scheduled to speak at the Jefferies 2011 ... is scheduled for Monday, June 6, 2011 at 8:30 ... webcast live during the conference and will be available ...
... ANN ARBOR, Mich., June 3, 2011 Everist Genomics ... OncoDefender-CRC assay, a molecular prognostic test for early-stage colorectal ... Society of Clinical Oncology (ASCO) Annual Meeting, which will ... (Logo: http://photos.prnewswire.com/prnh/20110110/NY26865LOGO ) OncoDefender-CRC examines expression ...
Cached Medicine Technology:Everist Genomics Announces New Data on OncoDefender™- CRC Test for Predicting Recurrence Risk for Stage I and II Colorectal Cancer Patients 2Everist Genomics Announces New Data on OncoDefender™- CRC Test for Predicting Recurrence Risk for Stage I and II Colorectal Cancer Patients 3Everist Genomics Announces New Data on OncoDefender™- CRC Test for Predicting Recurrence Risk for Stage I and II Colorectal Cancer Patients 4
(Date:7/28/2014)... A young couple from a small ... in the media today about parents accidentally leaving children ... of minutes in a hot car. July 31 is ... Emergency Medical Services at NHTSA. , Shaun and Kimberly ... that it’s all too easy to get distracted, the ...
(Date:7/28/2014)... Mediaplanet announced distribution of ... 12th, a campaign that aims to raise awareness about ... industry leader TEALUX , a premium loose leaf ... campaign provides readers with educational insight about the accessibility ... the industry forward and make conscious organic choices an ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 The website, ... for the healthcare industry, went live in January 2014. ... the basic standards of excellence that comprise the web’s ... excellence in Healthcare. , “What pleases me the most ... content and usability categories,” said Joshua Snow, web manager, ...
(Date:7/28/2014)... According to a new market research ... IV-IV, sapphire), Deposition Technology (CVD, MBE, HVPE, ... and Geography-2013-2020", published by MarketsandMarkets, the market is ... from 2014 to 2020 and reach $104.55 billion ... and 88 figures spread through 342 pages and ...
(Date:7/28/2014)... Lake City, Utah (PRWEB) July 28, 2014 Irresistible ... gift delivered by Spoonful of Comfort. The online gifting company specializes ... they are practical. , The New Baby package starts with home-from-the-hospital ... jar of soup , 6 rolls , ... smiles , The soup is ready to heat and ...
Breaking Medicine News(10 mins):Health News:'Precious Cargo' App Released to Help Save Babies from the Dangers of Being Accidentally Left Behind in Hot Cars 2Health News:Mediaplanet's "Organic Living" Campaign Raises Awareness About What Nature Invented, With the Help of Partner TEALUX 2Health News:Abington Health Website Named Best in Class 2Health News:Compound Semiconductor Market by Type (III-V, II-VI, IV-IV, sapphire), Deposition Technology, Product Worth $104.55 Billion in 2020 - New Report by MarketsandMarkets 2Health News:Compound Semiconductor Market by Type (III-V, II-VI, IV-IV, sapphire), Deposition Technology, Product Worth $104.55 Billion in 2020 - New Report by MarketsandMarkets 3Health News:Compound Semiconductor Market by Type (III-V, II-VI, IV-IV, sapphire), Deposition Technology, Product Worth $104.55 Billion in 2020 - New Report by MarketsandMarkets 4Health News:Spoonful of Comfort Announces "New Baby" Gift Package 2
... concerns about erosion of RN and patient care ... today criticized the action by the Service Employees ... affiliate, United Healthcare Workers-West.In a statement today, Rose ... registered nurses in most of the hospitals where ...
... called astrocytes help to cause the urge to sleep that ... funded by the National Institutes of Health. The cells ... are inhibited by caffeine. , "Millions of Americans suffer from ... from pilots to combat soldiers have jobs where sleepiness ...
... Wednesday,s winter storm has impacted the blood ... blood drives were cancelled or postponed on Wednesday ... appointments, resulting in a 32.5% reduction of Penn-Jersey ... 6 blood drives that were scheduled to collect ...
... help spread awareness of Foundation,s mission and servicesSHORT HILLS, ... Foundation, the national, non-profit organization dedicated to finding cures ... lives of people living with paralysis, announced today that ... show "Brothers and Sisters," has been named a celebrity ...
... over 20 now have the condition, while 30% are pre-diabetic, ... most recent analysis of data on diabetes in the United ... and older have the condition, 40 percent of whom have ... patients than noted in a previous study, although the percentage ...
... Washington, D.C. A three-year award from the ... of Population Affairs to Georgetown University,s Institute for ... in California and Massachusetts to offer the Standard ... planning method developed by Institute researchers. , In ...
Cached Medicine News:Health News:CNA/NNOC Criticizes SEIU Trusteeship: Cites Concerns for Erosion of RN and Patient Care Standards 2Health News:Support cells, not neurons, lull the brain to sleep 2Health News:Support cells, not neurons, lull the brain to sleep 3Health News:Blood Donors Needed in Wake of Winter Storm 2Health News:Dave Annable Named Christopher & Dana Reeve Foundation Ambassador 2Health News:Diabetes Keeps Rising Among U.S. Adults 2Health News:Diabetes Keeps Rising Among U.S. Adults 3Health News:Bringing easy-to-use, effective natural family planning to American women 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: